Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hepatitis A vaccination efficacy in elderly travelers
NL-OMON34411Phase 4Recruiting
- Sponsor
- Alysis Zorggroep
- Start
- Oct 2010
- Modality
- Whole Inactivated Vaccines → Inactivated Vaccines → Prophylactic Vaccines → Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 4, open-label trial of Hepatitis A virus vaccine in hepatitis A (HAV) (2 cohorts), sponsored by Alysis Zorggroep. Primary endpoint: Time to protective hepatitis A antibody level. Started Oct 2010; status: recruiting.
02
Drugs
Hepatitis A virus vaccine
03
Conditions
hepatitis A (HAV)
Beyond the preview
Go deeper on NL-OMON34411.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON34411.